In situ activation pattern of Drosophila EGF receptor pathway during development

Science

Volumn 277, Issue 5329, 1997, Pages 1103-1106

  Gabay, Limor ^a   Seger, Rony ^a   Shilo, Ben Zion ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE;

ANTIBODY SPECIFICITY; ARTICLE; CROSS REACTION; DROSOPHILA; EMBRYO DEVELOPMENT; ENZYME ACTIVATION; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; IMMUNOHISTOCHEMISTRY; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; BODY PATTERNING; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL DIFFERENTIATION; DROSOPHILA; DROSOPHILA PROTEINS; EPIDERMAL GROWTH FACTOR; EYE PROTEINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, INSECT; MEMBRANE PROTEINS; MUTATION; NERVE TISSUE PROTEINS; PHOSPHORYLATION; PHOTORECEPTORS, INVERTEBRATE; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 0030866482     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.277.5329.1103     Document Type: Article

References (39)

1. R. Seger and E. G. Krebs, FASEB J. 9, 726 (1995).
2. R. Schweitzer and B.-Z. Shilo, Trends Genet. 13, 191 (1997).
3. E. Raz and B. Z. Shilo, Genes Dev. 7, 1937 (1993).
4. F. J. Diaz-Benjumea and A. Garcia-Bellido, Proc. R. Soc. London Ser. B 242, 36 (1990).
5. M. Freeman, Cell 87, 651 (1996).
6. M. Tio and K. Moses, Development 124, 343 (1997).
7. T. Schüpbach, Cell 49, 699 (1987); A. González-Reyes, H. Elliot, D. St. Johnston, Nature 375, 654 (1995); S. Roth, F. S. Neuman-Silberberg, G. Barcelo, T. Schüpbach, Cell 81, 967 (1995).
8. T. Schüpbach, Cell 49, 699 (1987); A. González-Reyes, H. Elliot, D. St. Johnston, Nature 375, 654 (1995); S. Roth, F. S. Neuman-Silberberg, G. Barcelo, T. Schüpbach, Cell 81, 967 (1995).
9. T. Schüpbach, Cell 49, 699 (1987); A. González-Reyes, H. Elliot, D. St. Johnston, Nature 375, 654 (1995); S. Roth, F. S. Neuman-Silberberg, G. Barcelo, T. Schüpbach, Cell 81, 967 (1995).
10. R. Schweitzer, M. Shaharabany, R. Seger, B.-Z. Shilo, Genes Dev. 9, 1518 (1995).
11. M. Golembo, E. Raz, B.-Z. Shilo, Development 122, 3363 (1996).
12. M. Freeman, C. Klämbt, C. S. Goodman, G. M. Rubin, Cell 69, 963 (1992); R. Schweitzer, R. Howes, R. Smith, B.-Z. Shilo, M. Freeman, Nature 376, 699 (1995); M. Golembo, R. Schweitzer, M. Freeman, B.-Z. Shilo, Development 122, 223 (1996).
13. M. Freeman, C. Klämbt, C. S. Goodman, G. M. Rubin, Cell 69, 963 (1992); R. Schweitzer, R. Howes, R. Smith, B.-Z. Shilo, M. Freeman, Nature 376, 699 (1995); M. Golembo, R. Schweitzer, M. Freeman, B.-Z. Shilo, Development 122, 223 (1996).
14. M. Freeman, C. Klämbt, C. S. Goodman, G. M. Rubin, Cell 69, 963 (1992); R. Schweitzer, R. Howes, R. Smith, B.-Z. Shilo, M. Freeman, Nature 376, 699 (1995); M. Golembo, R. Schweitzer, M. Freeman, B.-Z. Shilo, Development 122, 223 (1996).
15. i)-Val-Ala-Thr corresponding to the phosphorylated form of the ERK-activation loop.
16. The general rabbit polyclonal antibody to ERK (Ab. 7884) was generated against a 23-amino acid peptide from subdomain Xl [K. C. Gause et al., J. Biol. Chem. 268, 16124 (1993)].
17. Y. Yung et al., FEBS Lett. 408, 292 (1997).
18. W. Biggs and S. L. Zipursky, Proc. Natl. Acad. Sci. U.S.A. 89, 6295 (1992).
19. D2f (8) or Schneider cells were incubated with medium containing sSpitz for 12 min. After incubation the cells were lysed with sample buffer, and lysates were separated on a 12% SDS-polyacrylamide gel electrophoresis (PAGE) gel. After blotting to nitrocellulose, the general antibody to ERK was detected with a 1/10,000 dilution of Ab. 7884, and dp-ERK was detected with a 1/2000 dilution of anti-dp-ERK. For induction of dp-ERK in embryos, embryos containing sev-hs-Gal4 and UAS-secreted Spitz4a were collected for 5 hours, administered heat shock at 37°C for 20 min, incubated at 29°C for 1 hour, and lysed. Control embryos of the same genotype were treated identically, but heat shock was eliminated.
20. Cells were fixed in 4% formaldehyde (fresh) for 20 min. After washes, the cells were permeabilized with 0.5% Triton X-100 in phosphate-buffered saline for 5 min. Subsequent steps were standard. Fresh embryos were fixed in 8% formaldehyde and kept in 100% methanol at -20°C. All washes were done with PBS, 0.1% Tween-20. In cases of DAB or fluorescent double stainings, the second primary antibody was added only after completion of washes of the secondary antibody to dp-ERK to ensure efficient staining and avoid cross-reactivity. All other aspects of staining were standard. After preincubation of anti-dp-ERK with the phosphorylated peptide antigen, staining was eliminated. Other antibodies used include rabbit anti-β-Gal (Cappel). Secondary antibodies include horse-radish peroxidase-conjugated goat anti-mouse immunoglobulin G (IgG) and fluorescein isothiocyanate-or LRSC-conjugated goat anti-mouse IgG+IgM or anti-rabbit IgG (Jackson labs).
21. L. Gabay, R. Seger, B.-Z. Shilo, Development 124, 3535 (1997).
22. E. Bier et al., Genes Dev. 4, 190 (1990).
23. A. L. Kolodkin, A. T. Pickup, D. M. Lin, C. S. Goodman, U. Banerjee, Development 120, 1731 (1994).
24. Y. T. Ip, R. E. Park, D. Kosman, E. Bier, M. Levine, Genes Dev. 6, 1728 (1992).
25. R. Noll, M. A. Sturtevant, R. R. Gollapudi, E. Bier, Development 120, 2329 (1994); H. Xiao, L. A. Hrdlicka, J. Nambu, Mech. Dev. 58, 65 (1996).
26. R. Noll, M. A. Sturtevant, R. R. Gollapudi, E. Bier, Development 120, 2329 (1994); H. Xiao, L. A. Hrdlicka, J. Nambu, Mech. Dev. 58, 65 (1996).
27. B. J. Rutledge, K. Zhang, E. Bier, Y. N. Jan, N. Perrimon, Genes Dev. 6, 1503 (1992); P. zur Lage, Y. N. Jan, A. P. Jarman, Curr. Biol. 7, 166 (1997); M. Okabe and H. Okano, Development 124, 1045 (1997).
28. B. J. Rutledge, K. Zhang, E. Bier, Y. N. Jan, N. Perrimon, Genes Dev. 6, 1503 (1992); P. zur Lage, Y. N. Jan, A. P. Jarman, Curr. Biol. 7, 166 (1997); M. Okabe and H. Okano, Development 124, 1045 (1997).
29. B. J. Rutledge, K. Zhang, E. Bier, Y. N. Jan, N. Perrimon, Genes Dev. 6, 1503 (1992); P. zur Lage, Y. N. Jan, A. P. Jarman, Curr. Biol. 7, 166 (1997); M. Okabe and H. Okano, Development 124, 1045 (1997).
30. C. Klämbt, J. R. Jacobs, C. S. Goodman, Cell 64, 801 (1991); E. Raz and B.-Z. Shilo, Development 114, 113 (1992); H. Scholz, E. Sadlowski, A. Klaes, C. Klämbt, Mech. Dev. 62, 79 (1997).
31. C. Klämbt, J. R. Jacobs, C. S. Goodman, Cell 64, 801 (1991); E. Raz and B.-Z. Shilo, Development 114, 113 (1992); H. Scholz, E. Sadlowski, A. Klaes, C. Klämbt, Mech. Dev. 62, 79 (1997).
32. C. Klämbt, J. R. Jacobs, C. S. Goodman, Cell 64, 801 (1991); E. Raz and B.-Z. Shilo, Development 114, 113 (1992); H. Scholz, E. Sadlowski, A. Klaes, C. Klämbt, Mech. Dev. 62, 79 (1997).
33. L. A. Perkins, I. Larsen, N. Perrimon, Cell 70, 225 (1992); L. A. Perkins, M. R. Johnson, M. B. Melnik, N. Perrimon, Dev. Biol. 180, 63 (1996).
34. L. A. Perkins, I. Larsen, N. Perrimon, Cell 70, 225 (1992); L. A. Perkins, M. R. Johnson, M. B. Melnik, N. Perrimon, Dev. Biol. 180, 63 (1996).
35. M. A. Sturtevant et al., Genes Dev. 7, 961 (1993).
36. Fixation of imaginal discs was carried out in 4% formaldehyde for 30 min. Wash solutions contained 0.2% Triton X-100. In contrast to anti-dp-ERK staining of embryos, which is highly reproducible, staining of imaginai discs is variable, for unknown reasons.
37. B. Schnepp, G. Grumbling, T. Donaldson, A. Simcox, Genes Dev. 10, 2302 (1996); A. A. Simcox et al., Dev. Biol. 177, 475 (1996).
38. B. Schnepp, G. Grumbling, T. Donaldson, A. Simcox, Genes Dev. 10, 2302 (1996); A. A. Simcox et al., Dev. Biol. 177, 475 (1996).
39. We thank Y. Dolginov and D. Zharhary (Sigma Israel Chemicals, Rehovot, Israel) for help preparing activated antibody to MAPK (dp-ERK), and A. Brand, S. Crews, M. Freeman, W. Gehring, E. Hafen, C. Klämbt, M. Leptin, M. Levine, L. Perkins, and N. Perrimon for providing antibodies and fly stocks. We thank members of the Shilo lab, R. Schweitzer, and T. Volk for critical reading of the manuscript. R.S. is an incumbent of the Samuel and Isabela Friedman Career Development Chair. Supported by a grant from the Dr. Josef Cohn Minerva Center for Biomembrane Research (R.S.) and by grants from the Tobacco Research Council, US-Israel binational fund, UK-Israel binational fund, and Minerva Foundation (B.-Z.S.).